Jacqueline Stone

1.5k total citations
19 papers, 702 citations indexed

About

Jacqueline Stone is a scholar working on Genetics, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jacqueline Stone has authored 19 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 8 papers in Neurology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jacqueline Stone's work include CNS Lymphoma Diagnosis and Treatment (8 papers), Acute Lymphoblastic Leukemia research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Jacqueline Stone is often cited by papers focused on CNS Lymphoma Diagnosis and Treatment (8 papers), Acute Lymphoblastic Leukemia research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Jacqueline Stone collaborates with scholars based in United States. Jacqueline Stone's co-authors include Lisa M. DeAngelis, Babak B. Navi, Samuel Singer, Mitchell S.V. Elkind, Alexander E. Merkler, Hooman Kamel, Costantino Iadecola, Natalie Cheng, Erkut Attar and Ivy Fearen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Jacqueline Stone

17 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacqueline Stone United States 9 233 209 161 160 149 19 702
Ashley Goss United States 12 99 0.4× 464 2.2× 731 4.5× 63 0.4× 127 0.9× 18 1.2k
Hans-Gerd Kehl Germany 16 147 0.6× 110 0.5× 406 2.5× 94 0.6× 57 0.4× 53 905
William Boisseau France 14 421 1.8× 225 1.1× 109 0.7× 137 0.9× 26 0.2× 35 722
M. Gardinali Italy 16 82 0.4× 100 0.5× 67 0.4× 18 0.1× 40 0.3× 32 593
Qian Han China 19 137 0.6× 396 1.9× 240 1.5× 10 0.1× 40 0.3× 52 893
Isao Kondô Japan 15 118 0.5× 51 0.2× 131 0.8× 26 0.2× 30 0.2× 51 941
Xiaozhou He China 19 56 0.2× 236 1.1× 292 1.8× 11 0.1× 260 1.7× 43 880
Yohann Repessé France 16 90 0.4× 56 0.3× 197 1.2× 41 0.3× 44 0.3× 51 908
A. Karim Ahmed United States 19 40 0.2× 56 0.3× 174 1.1× 17 0.1× 55 0.4× 48 942

Countries citing papers authored by Jacqueline Stone

Since Specialization
Citations

This map shows the geographic impact of Jacqueline Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Stone more than expected).

Fields of papers citing papers by Jacqueline Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Stone. The network helps show where Jacqueline Stone may publish in the future.

Co-authorship network of co-authors of Jacqueline Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline Stone. A scholar is included among the top collaborators of Jacqueline Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline Stone. Jacqueline Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Schaff, Lauren, Dean Carlow, Ryan Schofield, et al.. (2022). Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study. BMC Cancer. 22(1). 60–60. 8 indexed citations
4.
Schaff, Lauren, Uğur Sener, Igor T. Gavrilovic, et al.. (2020). Pilot Study of Glucarpidase in Combination with Rituximab and Methotrexate (MTX) in CNS Lymphoma (CNSL) (1409). Neurology. 94(15_supplement). 1 indexed citations
5.
Schaff, Lauren, Uğur Sener, Igor T. Gavrilovic, et al.. (2020). CTNI-61. PILOT STUDY OF REPEATED PLANNED GLUCARPIDASE FOLLOWING HIGH DOSE METHOTREXATE (HD-MTX) IN CNS LYMPHOMA (CNSL). Neuro-Oncology. 22(Supplement_2). ii56–ii56. 2 indexed citations
6.
Grommes, Christian, Minesh P. Mehta, Alexandra Miller, et al.. (2020). CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA. Neuro-Oncology. 22(Supplement_2). ii36–ii36. 1 indexed citations
7.
Grommes, Christian, Igor T. Gavrilovic, Alexandra Miller, et al.. (2019). Phase Ib of Copanlisib in Combination with Ibrutinib in Recurrent/Refractory Primary CNS Lymphoma (PCNSL). Blood. 134(Supplement_1). 1598–1598. 10 indexed citations
8.
Grommes, Christian, J. M. Wolfe, Igor T. Gavrilovic, et al.. (2018). Phase II of Single-Agent Ibrutinib in Recurrent/Refractory Primary (PCNSL) and Secondary CNS Lymphoma (SCNSL). Blood. 132(Supplement 1). 2965–2965. 15 indexed citations
9.
Navi, Babak B., Randolph S. Marshall, Samuel Singer, et al.. (2018). Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke. JAMA Neurology. 75(3). 379–379. 53 indexed citations
10.
Grommes, Christian, Jacqueline Stone, Craig Nolan, et al.. (2017). Phase 1B of ibrutinib and high-dose methotrexate for recurrent/refractory CNS lymphoma.. Journal of Clinical Oncology. 35(15_suppl). 7533–7533. 3 indexed citations
11.
Stone, Jacqueline & Lisa M. DeAngelis. (2016). Correction regarding data on blinatumomab-associated seizures. Nature Reviews Clinical Oncology. 13(10). 650–650. 1 indexed citations
12.
Stone, Jacqueline, Joanne Frankel Kelvin, & Lisa M. DeAngelis. (2016). Fertility preservation in primary brain tumor patients. Neuro-Oncology Practice. 4(1). 40–45. 16 indexed citations
13.
Merkler, Alexander E., Babak B. Navi, Samuel Singer, et al.. (2015). Diagnostic yield of echocardiography in cancer patients with ischemic stroke. Journal of Neuro-Oncology. 123(1). 115–121. 20 indexed citations
14.
Stone, Jacqueline, Jerome Graber, & Thomas Kaley. (2015). Pregnancy in Glioma Patients (S18.006). Neurology. 84(14_supplement). 1 indexed citations
15.
Stone, Jacqueline & Lisa M. DeAngelis. (2015). Cancer-treatment-induced neurotoxicity—focus on newer treatments. Nature Reviews Clinical Oncology. 13(2). 92–105. 193 indexed citations
16.
Navi, Babak B., Samuel Singer, Alexander E. Merkler, et al.. (2014). Cryptogenic Subtype Predicts Reduced Survival Among Cancer Patients With Ischemic Stroke. Stroke. 45(8). 2292–2297. 71 indexed citations
17.
Navi, Babak B., Samuel Singer, Alexander E. Merkler, et al.. (2014). Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology. 83(1). 26–33. 132 indexed citations
18.
Cheng, Natalie, Samuel Singer, Alexander E. Merkler, et al.. (2013). Abstract WP230: The Yield of Echocardiography in Cancer Patients with Suspected Cardioembolic Stroke. Stroke. 44(suppl_1). 1 indexed citations
19.
Stone, Richard M., L. B. Silverman, Wendy Stock, et al.. (2006). A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias. Journal of Clinical Oncology. 24(18_suppl). 6585–6585. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026